FDC Ltd made a modest beginning with marketing of vitamins and a range of prescription formulations.The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.
FDC initiated the concept of Oral Rehydration Salts (ORS) and today their pioneer brand Electral stands apart with a special identity- an impressive achievement in a fiercely competitive market.
The company product spectrum includes the following:Therapeutic Products-Anti Fungals/Dermatological,Anti-Anaemic,Anti-Diabetic,Anti-Diarrhoeals/ Intestinals/ ORS Anti-Haemorrhagics,Anti-Oxidants,Anti-Spasmodics,Antibiotics/Antibacterials,Antiemetic/ Antinauseant etc.Food-Vitamins And Nutraceuticals.Bulk Drug-Albuterol Sulfate,Betaxolol Hydrochloride,Brimonidine Tartrate,Bromhexine Hydrochloride,Cinnarizine etc,Active Pharmaceutical Ingredients (API) Under Development-Azelastine HCl,Brinzolamide,Duloxetine HCl,Gemifloxacine Mesylate,Latanoprost,Levo-Betaxolol HCl,Olopatadine HCl,Pregabalin,Rupatadine Fumarate,Voriconazole,etcview less –
FDC Limited Buyback Details
| Buyback Open Date | 12-April-2022 |
| Buyback Close Date | 27-April-2022 |
| offer Price | 475 Rs |
| Issue Size | 137.75 Crore |
| Size in Shares | 29,00,000 Equity Shares |
| Symbol | FDC |
| Face value | 1 |
| Listing At | NSE,BSE |
| Retail | 15% (4,35,000 Shares) |
| Public Announcement | Download |
| Letter of offer | Download |
FDC Limited Buyback Timetable
| Record Date | 19-February-2022 |
| Finalisation of Buyback Acceptance | 5-May-2022 |
| Last Date for settlment of bids | 29-April-2022 |
| Small Shareholders Ratio | 20 Equity Shares for every 307 Equity Shares held on the Record Date. |
| General Shareholders Ratio | 9 Equity Shares for every 592 Equity Shares held on the Record Date. |
FDC Limited Contact Details
FDC Limited
B-8, M.I.D.C. Industrial Estate,
Waluj – 431 130, Dist. Aurangabad
Phone: 91 240 255 4407
Email: [email protected]
Website: http://www.fdcindia.com/
FDC Limited Buyback Lead Managers
Sundae Capital Advisors Private Limited
Level 9, Platina, Plot No C – 59, ‘G’ Block
Bandra Kurla Complex, Bandra (East)
Mumbai – 400 051, Maharashtra, India
Tel. No. +91 22 6700 0639
Email: [email protected]
Investor Grievance e-mail id: [email protected]
Website: www.sundaecapital.com
SEBI Regn. No.: INM000012494
Validity Period: Permanent
Contact Person: Rajiv Sharma / Ridima Gulati
FDC Limited Buyback Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli (West)
Mumbai – 400 083, Maharashtra, India
Tel No.: +91 22 4918 6200
Fax No.: +91 22 4918 6195
Email id.: [email protected]
Website: www.linkintime.co.in
SEBI Regn. No.: INR000004058
Contact Person: Sumeet Deshpande
u3iauds11